Diseases, Conditions, Syndromes

Ebola vaccine developed in Canada shows promising results

A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...

Medical research

Virus kills melanoma in animal model, spares normal cells

Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, ...

Medical research

Viruses kill pancreatic tumors in preclinical model

(Medical Xpress) -- An intra-tumor injection of a virus prevented further growth of some pancreatic tumors and eradicated others in mouse models of pancreatic ductal adenocarcinoma. However, some tumors continued growing ...

Immunology

Antibodies are not required for immunity against some viruses

A new study turns the well established theory that antibodies are required for antiviral immunity upside down and reveals that an unexpected partnership between the specific and non-specific divisions of the immune system ...

Diseases, Conditions, Syndromes

Experimental NIH Sudan virus vaccine protects macaques

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine. ...

page 2 from 4